PURPOSE: Despite the lack of evidence to support its implementation in the clinical practice, induction chemotherapy (IC) before chemoradiotherapy (CRT) is often used in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). We retrospectively examined the tolerability, feasibility, and clinical outcome of both concepts in a single center analysis. PATIENTS AND METHODS: In all, 83 patients were treated between 2007 and 2010 with IC + CRT (n = 42) or CRT alone (n = 41). IC consisted of docetaxel, cisplatin and 5-fluorouracil (TPF), or cisplatin and 5-fluorouracil (PF). All patients were scheduled to receive 2 cycles of PF during concurrent CRT. Adverse events were assessed according to the common toxicity criter...
Objective: Toxicity analysis in patients of locally advanced head and neck carcinoma (LAHNC) when in...
Induction chemotherapy (IC) in locally advanced head and neck squamous cell carcinoma (LA HNSCC) has...
Background. We investigated the efficacy of cetuximab when added to induction chemotherapy followed ...
PURPOSE: Despite the lack of evidence to support its implementation in the clinical practice, induct...
Purpose The purpose of this study was to compare the survival of patients with locally advanced head...
AIM: The purpose of the study was to assess outcomes of locally advanced head and neck (LAHNC) treat...
Background: Platinum-based chemoradiation (CCRT) is the standard treatment for Locally Advanced Head...
BackgroundAlthough induction chemotherapy can reduce distant metastases in locally advanced head and...
Objective: Induction chemotherapy (IC) and concurrent chemoradiotherapy (CCRT) for locally advanced ...
International audiencePurposeBoth concurrent chemoradiotherapy (CT-RT) and cetuximab radiotherapy (c...
Background: To clarify the effect of induction chemotherapy (ICT) in patients with advanced pharynge...
Background:Objective of current study was to observe the local control, progression free survival an...
PURPOSE: To study the feasibility of induction chemotherapy added to concomitant cisplatin-based che...
Purpose Both concurrent chemoradiotherapy (CT-RT) and cetuximab radiotherapy (cetux-RT) have been es...
Abstract Background Concomitant chemotherapy and radiotherapy (chemoradiation; CRT) is the standard ...
Objective: Toxicity analysis in patients of locally advanced head and neck carcinoma (LAHNC) when in...
Induction chemotherapy (IC) in locally advanced head and neck squamous cell carcinoma (LA HNSCC) has...
Background. We investigated the efficacy of cetuximab when added to induction chemotherapy followed ...
PURPOSE: Despite the lack of evidence to support its implementation in the clinical practice, induct...
Purpose The purpose of this study was to compare the survival of patients with locally advanced head...
AIM: The purpose of the study was to assess outcomes of locally advanced head and neck (LAHNC) treat...
Background: Platinum-based chemoradiation (CCRT) is the standard treatment for Locally Advanced Head...
BackgroundAlthough induction chemotherapy can reduce distant metastases in locally advanced head and...
Objective: Induction chemotherapy (IC) and concurrent chemoradiotherapy (CCRT) for locally advanced ...
International audiencePurposeBoth concurrent chemoradiotherapy (CT-RT) and cetuximab radiotherapy (c...
Background: To clarify the effect of induction chemotherapy (ICT) in patients with advanced pharynge...
Background:Objective of current study was to observe the local control, progression free survival an...
PURPOSE: To study the feasibility of induction chemotherapy added to concomitant cisplatin-based che...
Purpose Both concurrent chemoradiotherapy (CT-RT) and cetuximab radiotherapy (cetux-RT) have been es...
Abstract Background Concomitant chemotherapy and radiotherapy (chemoradiation; CRT) is the standard ...
Objective: Toxicity analysis in patients of locally advanced head and neck carcinoma (LAHNC) when in...
Induction chemotherapy (IC) in locally advanced head and neck squamous cell carcinoma (LA HNSCC) has...
Background. We investigated the efficacy of cetuximab when added to induction chemotherapy followed ...